Charles Miller, a graduate of the MTSA anesthesia program in Nashville, TN, brings a wealth of experience to the field, including OB anesthesia, regional anesthesia, and cardiac anesthesia. During his time as a Resident Registered Nurse Anesthetist (RRNA) at Vanderbilt University Medical Center, he engaged in innovative research, laying the foundation for his expertise in opioid-free pain management through ERAS protocols. Motivated by a strong desire to improve treatment options, Charles pursued training and a greater understanding of Ketamine Infusion Therapy for mental health disorders and was the first to introduce it into Chattanooga’s healthcare landscape.
As the Founder and Chief Medical Officer of Scenic City Neurotherapy since 2019, Charles has led the clinic to become a top provider of non-opioid, non-narcotic treatments for chronic pain and mood disorders worldwide. Scenic City Neurotherapy’s growth is a result of Charles’ intentionally established processes. Further, the clinic’s unique success is attributed to Charles’ commitment to education and empowerment of patients, leading to meaningful improvements in their quality of life.
Charles’ commitment to superior treatment options led to the development of the Minimally Stimulated Ketamine Infusion Therapy (MSKIT) protocol, positioning him as a thought leader in Psychoplastogenic Medicine. His innovative approach extends to the development of life-changing Psychoplastogenic Treatments, such as the innovative combination of MSKIT with Transcranial Magnetic Stimulation (TMS), aimed at increasing positive patient outcomes and advancing the conversation surrounding the optimal utilization of psychoplastogens in the treatment of mental health.
Continuing his pursuit of innovation, Charles actively contributes Scenic City Neurotherapy’s clinical data to research initiatives through the Osmind community. He also serves as a valued member of the Osmind Community Advisory Board (CAB), advocating for advancements in mental health treatment and research alongside fellow clinician leaders.
Charles participates in speaking engagements at conferences nationwide and advocates for best practices in ketamine infusion therapy across the United States. His efforts extend to educating healthcare providers, patients, and the wider public on the effective use of Ketamine Infusion Therapy and TMS for managing mental health and chronic pain conditions.
